AKAM
Price
$91.71
Change
-$8.22 (-8.23%)
Updated
Oct 14 closing price
Capitalization
15.66B
21 days until earnings call
Intraday BUY SELL Signals
WEAV
Price
$7.39
Change
+$0.02 (+0.27%)
Updated
Oct 14 closing price
Capitalization
592.92M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKAM vs WEAV

AKAM vs WEAV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AKAM vs. WEAV commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAM is a Hold and WEAV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AKAM with price predictions
Oct 14, 2026

AKAM sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AKAM moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AKAM as a result. In 51 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for AKAM turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 28 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.

AKAM moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for AKAM's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where AKAM advanced for three days, in 208 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

AKAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 144 of 253 cases where AKAM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.298) is normal, around the industry mean (17.861). P/E Ratio (39.489) is within average values for comparable stocks, (159.605). Projected Growth (PEG Ratio) (1.177) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (3.598) is also within normal values, averaging (104.490).

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. AKAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

A.I.Advisor
a Summary for WEAV with price predictions
Oct 14, 2026

WEAV in downward trend: price may drop because broke its higher Bollinger Band on September 23, 2026

WEAV broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In 30 of the 37 cases the stock fell afterwards. This puts the odds of success at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 60 cases where WEAV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for WEAV turned negative on September 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WEAV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on WEAV as a result. In 63 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

Following a +0.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where WEAV advanced for three days, in 231 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 196 of 223 cases where WEAV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.978) is normal, around the industry mean (7.432). WEAV has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (2.228) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. WEAV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

FUNDAMENTALS RATINGS
AKAM: Fundamental Ratings
AKAM
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
75
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKAMWEAV
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
61%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
88%
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (AKAM: $91.71 vs. WEAV: $7.39)
Brand notoriety: AKAM and WEAV are both not notable
AKAM represents the Computer Communications, while WEAV is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: AKAM: 200% vs. WEAV: 35%
Market capitalization -- AKAM: $15.66B vs. WEAV: $592.92M
AKAM [@Computer Communications] is valued at $15.66B. WEAV’s [@Services to the Health Industry] market capitalization is $592.92M. The market cap for tickers in the [@Computer Communications] industry ranges from $48.8K to $3.78T. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $45.33B. The average market capitalization across the [@Computer Communications] industry is $35.76B. The average market capitalization across the [@Services to the Health Industry] industry is $2.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAM’s FA Score shows that 1 FA rating(s) are green while WEAV’s FA Score has 0 green FA rating(s).

  • AKAM’s FA Score: 1 green, 4 red.
  • WEAV’s FA Score: 0 green, 5 red.
According to our system of comparison, WEAV is a better buy in the long-term than AKAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAM’s TA Score shows that 5 TA indicator(s) are bullish while WEAV’s TA Score has 3 bullish TA indicator(s).

  • AKAM’s TA Score: 5 bullish, 5 bearish.
  • WEAV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AKAM is a better buy in the short-term than WEAV.

Price Growth

AKAM (@Computer Communications) experienced а -12.33% price change this week, while WEAV (@Services to the Health Industry) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Computer Communications industry was -7.83%. For the same industry, the average monthly price growth was -10.09%, and the average quarterly price growth was +3.20%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -3.94%. For the same industry, the average monthly price growth was -3.43%, and the average quarterly price growth was +12.45%.

Reported Earning Dates

AKAM is expected to report earnings on Nov 05, 2026.

WEAV is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Computer Communications (-7.83% weekly)

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

@Services to the Health Industry (-3.94% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
AKAM
Daily Signal:
Gain/Loss:
WEAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGIO30.970.76
+2.52%
Agios Pharmaceuticals
ALPS0.35N/A
-0.03%
Alps Group Inc.
XPEV9.42-0.33
-3.38%
XPeng
MAGN10.59-0.50
-4.51%
Magnera Corporation
YMT0.82-0.05
-6.13%
Yimutian Inc

AKAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKAM has been loosely correlated with DOCN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AKAM jumps, then DOCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAM
1D Price
Change %
AKAM100%
-8.23%
DOCN - AKAM
55%
Loosely correlated
-14.76%
AFRM - AKAM
47%
Loosely correlated
-9.47%
ROP - AKAM
46%
Loosely correlated
+1.16%
EVH - AKAM
46%
Loosely correlated
+2.83%
WEAV - AKAM
45%
Loosely correlated
+0.27%
More

WEAV and

Correlation & Price change

A.I.dvisor indicates that over the last year, WEAV has been loosely correlated with QTWO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if WEAV jumps, then QTWO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WEAV
1D Price
Change %
WEAV100%
+0.27%
QTWO - WEAV
61%
Loosely correlated
+0.25%
DOCN - WEAV
58%
Loosely correlated
-14.76%
NOW - WEAV
55%
Loosely correlated
+0.99%
DBX - WEAV
55%
Loosely correlated
+0.06%
HUBS - WEAV
54%
Loosely correlated
+2.24%
More